SCHRODER INVESTMENT MANAGEMENT GROUP

Position in VKTX — Viking Therapeutics, Inc.

CIK 1086619 London, X0

Position in VKTX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$5,982,348

-$1,565,169 QoQ

Shares Held

183,846

-14.3% QoQ

Ownership

0.158%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $603,082,920 across 77 Biotechnology names. VKTX ranks #28 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	163,898	$73,187,011
2	TECH	BIO-TECHNE Corp	1,197,214	$62,566,403
3	EXEL	Exelixis, Inc.	525,533	$22,540,109
4	ALNY	Alnylam Pharmaceuticals, Inc.	66,662	$22,056,454
5	SLNO	Soleno Therapeutics Inc	648,827	$21,722,727
6	MDGL	Madrigal Pharmaceuticals, Inc.	39,852	$20,861,326
7	INSM	INSMED Inc	119,958	$19,615,531
8	VERA	Vera Therapeutics, Inc.	484,381	$19,486,647

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,982,348	183,846	-14.3%	Shares	Sole	2026-05-14
2025-12-31	$7,547,517	214,540	+46.4%	Shares	Sole	2026-02-13
2025-09-30	$3,852,358	146,589	-54.1%	Shares	Sole	2025-11-13
2025-06-30	$8,461,503	319,302	+89.1%	Shares	Sole	2025-08-13
2025-03-31	$4,077,292	168,832	+181.4%	Shares	Sole	2025-05-13
2024-12-31	$2,414,158	59,994	-39.8%	Shares	Sole	2025-02-12
2024-09-30	$6,304,789	99,586	-2.0%	Shares	Sole	2024-11-13
2024-06-30	$5,387,724	101,636	—	Shares	Sole	2024-08-12
No filing history on record for this holder in this stock.